Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Clinical and Experimental Reproductive Medicine ; : 143-147, 2013.
Article in English | WPRIM | ID: wpr-34819

ABSTRACT

Oocyte in vitro maturation (IVM) is an assisted reproductive technology in which oocytes are retrieved from the antral follicles of unstimulated or minimally stimulated ovaries. IVM of human oocytes has emerged as a promising procedure. This new technology has advantages over controlled ovarian stimulation such as reduction of costs, simplicity, and elimination of ovarian hyperstimulation syndrome. By elimination or reduction of gonadotropin stimulation, IVM offers eligible infertile couples a safe and convenient form of treatment, and IVM outcomes are currently comparable in safety and efficacy to those of conventional in vitro fertilization. IVM has been applied mainly in patients with polycystic ovary syndrome or ultrasound-only polycystic ovaries, but with time, the indications for IVM have expanded to other uncommon situations such as fertility preservation, as well as to normal responders. In this review, the current clinical experiences with IVM will be described.


Subject(s)
Female , Humans , Family Characteristics , Fertility Preservation , Fertilization in Vitro , Gonadotropins , In Vitro Oocyte Maturation Techniques , Infertility , Oocytes , Ovarian Hyperstimulation Syndrome , Ovary , Ovulation Induction , Polycystic Ovary Syndrome , Reproductive Techniques, Assisted
2.
Clinical and Experimental Reproductive Medicine ; : 153-160, 2012.
Article in English | WPRIM | ID: wpr-27089

ABSTRACT

OBJECTIVE: The aim of this study was to compare vitrification optimization of mouse embryos using electron microscopy (EM) grid, cryotop, and thin plastic strip (TPS) containers by evaluating developmental competence and apoptosis rates. METHODS: Mouse embryos were obtained from superovulated mice. Mouse cleavage-stage, expanded, hatching-stage, and hatched-stage embryos were cryopreserved in EM grid, cryotop, and TPS containers by vitrification in 15% ethylene glycol, 15% dimethylsulfoxide, 10 microg/mL Ficoll, and 0.65 M sucrose, and 20% serum substitute supplement (SSS) with basal medium, respectively. For the three groups in which the embryos were thawed in the EM grid, cryotop, and TPS containers, the thawing solution consisted of 0.25 M sucrose, 0.125 M sucrose, and 20% SSS with basal medium, respectively. Rates of survival, re-expansion, reaching the hatched stage, and apoptosis after thawing were compared among the three groups. RESULTS: Developmental competence after thawing of vitrified expanded and hatching-stage blastocysts using cryotop and TPS methods were significantly higher than survival using the EM grid (p<0.05). Also, apoptosis positive nuclei rates after thawing of vitrified expanded blastocysts using cryotop and TPS were significantly lower than when using the EM grid (p<0.05). CONCLUSION: The TPS vitrification method has the advantages of achieving a high developmental ability and effective preservation.


Subject(s)
Animals , Mice , Apoptosis , Blastocyst , Dimethyl Sulfoxide , Embryonic Structures , Ethylene Glycol , Ethylenes , Ficoll , Mental Competency , Microscopy, Electron , Plastics , Sucrose , Vitrification
3.
Clinical and Experimental Reproductive Medicine ; : 87-92, 2011.
Article in English | WPRIM | ID: wpr-70204

ABSTRACT

OBJECTIVE: This study aimed to determine the safety and clinical effect of artificial shrinkage (AS) in terms of assisted hatching of fresh blastocysts. Also, we evaluated the correlation between patient age and the effect of AS on clinical outcome. METHODS: Two AS methods, using a 29-gauge needle and laser pulse, were compared. Seventy-three blastocysts were shrunk using a 29-gauge needle and the same number of other blastocysts were shrunk by a laser pulse. We evaluated the shrunken blastocysts hourly and considered them viable if they re-expanded >70%. Blastocyst transfer cycles (n=134) were divided into two groups: a control group consisted of the cycles whose intact embryos were transferred (n=100), while the AS group consisted of the cycles whose embryos were replaced following AS (n=34). The implantation and pregnancy rates of the control group and AS group were compared (p<0.05). RESULTS: The re-expansion rates of the 29-gauge needle and laser pulse AS groups were similar (56 [76.7%] vs. 62 [84.9%], respectively). All of the remaining shrunken blastocysts were re-expanded within 2 hours. There was no degeneration of shrunken blastocysts. The total and clinical pregnancy rate of the AS group (23 [67.6%]; 20 [58.8%], respectively) was significantly higher than that of the control group (47 [47.0%]; 39 [39.0%], respectively). In the older patient group, there was no difference in the clinical outcomes between the AS and control groups. CONCLUSION: These results suggest that AS of blastocoele cavity, followed by the transfer, would be a useful approach to improve the clinical outcome in cycles in which fresh blastocyst stage embryos are transferred.


Subject(s)
Humans , Blastocyst , Embryo Transfer , Embryonic Structures , Fertilization in Vitro , Needles , Pregnancy Rate
4.
The Journal of the Korean Orthopaedic Association ; : 213-219, 2008.
Article in Korean | WPRIM | ID: wpr-645137

ABSTRACT

PURPOSE: The results of Sugioka's transtrochanteric rotational osteotomy are controversial. While many Japanese studies have reported favorable results, European and American studies have been disappointing. We present the results of Sugioka's rotational osteotomy for extensive osteonecrosis of the femoral head in young patients. METHODS AND MATERIALS: Between April. 1994 and May. 2004, Sugioka's osteotomy was performed for osteonecrosis involving a large part of the weight bearing area on 49 hips (46 patients). Of these 49 hips, 45 (43 patients) were available for follow-up. The patients were followed up for at least 2 years with an average of 52 months (range: 24-132 months). The major causes of osteonecrosis were chronic alcohol abuse in 33 hips. The mean age of the patients at the time of surgery was 31 years (range: 21-46), and the male to female ratio was 39:6. Six, 17 and 22 hips were classified as stage IIA, IIb and III using the Ficat and Alert classification, respectively. RESULTS: Thirty three of the 45 hips (74%) survived clinically and radiologically. Of these, the clinical results were excellent, good and fair in 15, 12 and 6 hips, respectively. Major complications were encountered in 12 hips [Progressive severe varus deformity in 7 hips (15%)], femur neck fracture in 3 hips (6%) and deep infection in 2 hips (4%). Among these 12 hips, seven hips (15%) required secondary THA. Five other hips (11%) were also subsequently converted to THA due to progressive collapse of the femoral head after the transtrochanteric osteotomy. CONCLUSION: Transtrochanteric osteotomy can be used to treat osteonecrosis of the femoral head in young patients with extensive necrotic lesions of the femoral head. However, Sugioka osteotomy should be used with caution due to its high incidence of complications.


Subject(s)
Female , Humans , Male , Alcoholism , Asian People , Congenital Abnormalities , Femoral Neck Fractures , Follow-Up Studies , Head , Hip , Hip Joint , Incidence , Osteonecrosis , Osteotomy , Tacrine , Weight-Bearing
5.
Korean Journal of Fertility and Sterility ; : 133-139, 2004.
Article in Korean | WPRIM | ID: wpr-160380

ABSTRACT

OBJECTIVE: To investigate the association of FSH receptor (FSHR) polymorphism at position 680 with outcomes of controlled ovarian hyper-stimulation for IVF-ET in Korean women. Design: Genetic polymorphism analysis. MATERIALS AND METHODS: The FSHR polymorphism was analyzed by PCR-RFLP in 172 ovulatory women below the age of 40 year. Patients with polycystic ovary syndrome, endometriosis, or previous history of ovarian surgery were excluded. RESULTS: Genotype distribution was 41.9% for the Asn/Asn, 47.7% for the Asn/Ser, and 10.5% for the Ser/Ser FSHR genotype group. There was no difference in age of subjects and infertility diagnosis between genotype groups. When the patients were grouped according to their FSHR genotype, the basal levels of FSH (day 3) were significantly different among the three groups (6.0+/-0.3 IU/L (mean+/-SEM), 5.8+/-0.3 IU/L, and 8.6+/-1.2 IU/L for the Asn/Asn, Asn/Ser, and Ser/Ser groups, respectively, p=0.002). The Ser/Ser group showed a higher total doses of gonadotropins required to achieve ovulation induction, and a lower serum estradiol levels at the time of hCG administration compared with other two groups, but the differences were of no statistical significance. The numbers of oocytes retrieved were significantly different among the three groups (8.6+/-0.8, 9.9+/-0.6, and 6.3+/-0.9, for the Asn/Asn, Asn/Ser, and Ser/Ser groups, respectively, p=0.049). Clinical pregnancy rates were 42.4%, 25.9%, and 29.4% for the Asn/Asn, Asn/Ser, and Ser/Ser groups, respectively. CONCLUSION: Homozygous Ser/Ser genotype of FSHR polymorphism at position 680 was associated with decreased ovarian response to gonadotropin stimulation for IVF-ET.


Subject(s)
Female , Humans , Diagnosis , Embryo Transfer , Embryonic Structures , Endometriosis , Estradiol , Fertilization , Follicle Stimulating Hormone , Genotype , Gonadotropins , Infertility , Oocytes , Ovulation Induction , Polycystic Ovary Syndrome , Polymorphism, Genetic , Pregnancy Rate , Receptors, FSH
6.
Korean Journal of Obstetrics and Gynecology ; : 978-983, 2003.
Article in Korean | WPRIM | ID: wpr-107127

ABSTRACT

OBJECTIVE: To explore the incidence of fragile X premutation in patients with idiopathic premature ovarian failure, particularly in the Korean population. DESIGN: A prospective study. MATERIALS AND METHODS: Eighty-three women affected by idiopathic premature ovarian failure were recruited for this study. Patient with known causes of premature ovarian failure were excluded: cytogenetic abnormalities, prior chemotherapy, prior bilateral oophorectomy. DNA was extracted from peripheral blood. Fragile X (FRAXA) premutation was evaluated by PCR amplification of and Southern blot analysis for FMR1 gene. RESULTS: The FRAXA premutation was detected in three (3.6%) out of 83 patients with idiopathic premature ovarian failure. CONCLUSION: This result suggests that fragile X premutation screening is indicated in patients with idiopathic premature ovarian failure, particularly in the Korean population.


Subject(s)
Female , Humans , Blotting, Southern , Chromosome Aberrations , DNA , Drug Therapy , Fragile X Syndrome , Incidence , Mass Screening , Ovariectomy , Polymerase Chain Reaction , Primary Ovarian Insufficiency , Prospective Studies
8.
Korean Journal of Obstetrics and Gynecology ; : 1916-1922, 1997.
Article in Korean | WPRIM | ID: wpr-62590

ABSTRACT

The crown-rump length(CRL) remains the most accurate parameter used for gestational dating. We aimed to establish the early fetal growth with CRL range in Korean women. The CRL of 48 singleton pregnancies which resulted from in vitro fertilization and e mbryo transfer(IVF-ET) at SNUH were assessed two to six times in the first trimester by trans-vaginal ultrasonography. All women included in this study went on to deliver norma l infa-nts at 37 completed weeks or after weighing over 2.5 kg. And we also studied the r elationship between CRL(in millimeters) and gestational age(in days), and found that the fo llowing second-order polynomial might be applied either to expect CRL using the menstr ual gestational age, or to estimate gestational age using measured CRL(r2=0.980, p=0.000 1). CRL=0.0175(GA)2-1.049(GA)+19.17 GA=7.5593(CRL-3.45)1/2+29.97 Finally we compared our data with some of published articles which assessed CRL in spontaneous and induced pregnancies. In conclusion, this study establish the early fetal growth with CRL range in Korean women on the basis of exact ovulation timing using high resolution transvaginal ultrasonography. And these data will be of great use in the evaluation of fetal growth in the first trimester.


Subject(s)
Female , Humans , Pregnancy , Crown-Rump Length , Embryo Transfer , Embryonic Structures , Fertilization in Vitro , Fetal Development , Gestational Age , Ovulation , Pregnancy Trimester, First , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL